For the Inventor, By the Inventor

Enter assignee name

Electronic, India

Biocon Limited

USPTO Granted Patents = 111

CIPO Patents = 13

EPO Patents = 53

Trademarks = 1

Forward Citations = 339

Loading Chart...

Loading Chart...

206 inventors (with patents filed for the assignee):

Nnochiri Ekwuribe (29 out of 72 patents)

Ramakrishnan Melarkode (19 out of 21 patents)

Kedarnath Nanjund Sastry (18 out of 19 patents)

4. Balasingam Radhakrishnan (16 out of 37 patents)

5. Nagaraj Govindappa (15 out of 16 patents)

6. Laxmi Adhikary (11 out of 12 patents)

7. Sambasivam Ganesh (11 out of 13 patents)

8. Pradip Nair (10 out of 11 patents)

9. Maria Melina Soares (10 out of 11 patents)

10. Sanjay Tiwari (10 out of 25 patents)

11. Harish Iyer (10 out of 17 patents)

12. Jose Enrique Montero Casimiro (9 out of 12 patents)

13. Shrikumar Suryanarayan (9 out of 18 patents)

14. Kenneth D James (9 out of 10 patents)

15. Mark A Miller (8 out of 172 patents)

Core Competencies:

Immunomodulatory Proteins

Monoclonal Antibodies

Crystalline Forms

Peptide Mapping

EGFR Targeted Therapy

Fusion Proteins

Insulin Analogues

Cancer Immunotherapy

Fucosylation Control

Pharmaceutical Formulations

Protein Purification

Fermentation Processes

111 patents: Sort by Forward Citations

1. 12509488 - Preparative crystallization of recombinant human insulin (2025-12-30),

2. 12351636 - Fusion immunomodulatory proteins and methods for making same (2025-07-08),

3. 12098136 - Crystalline forms of lenalidomide (2024-09-24),

4. 12049632 - Anti-EGFR1-PD1 targeted/immunomodulatory fusion protein (2024-07-30),

5. 11981743 - Monoclonal antibody and a method thereof (2024-05-14),

6. 11629120 - Trisodium sacubitril valsartan and process for its preparation (2023-04-18),

7. 11530403 - Rapid and efficient de-glycosylation of glycoproteins (2022-12-20),

8. 11442067 - Peptide mapping method for sequence identification of insulin and insulin analogues (2022-09-13),

9. 11340238 - Method for detecting neutralizing antibodies against recombinant human insulin in human serum (2022-05-24),

10. 11242401 - Monoclonal antibody and a method of use for the treatment of lupus (2022-02-08),

11. 11231384 - Humidity sensor (2022-01-25),

12. 11203585 - Crystalline forms of lenalidomide (2021-12-21),

13. 11066439 - Synthesis of liraglutide (2021-07-20),

14. 11060097 - Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins (2021-07-13),

15. 11059813 - Polymorphic forms of Dasatinib (2021-07-13),

Biocon Limited is a leading biopharmaceutical company based in India. It specializes in research, development, and manufacturing of innovative therapies and biochemicals. With a focus on biosimilars, Biocon has built a strong presence in the global healthcare market. The company's mission is to enhance access to affordable healthcare solutions and improve the lives of patients. Through cutting-edge technology and strategic collaborations, Biocon continues to drive advancements in biotechnology and contribute to the well-being of individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 13 2026

111 Patents

#1 in Electronic

#20 in India

#6,927 in the World

Electronic, India

Biocon Limited

Forward Citations = 339

206 inventors:

Nnochiri Ekwuribe (29 out of 72 patents)

Ramakrishnan Melarkode (19 out of 21 patents)

Kedarnath Nanjund Sastry (18 out of 19 patents)

4. Balasingam Radhakrishnan (16 out of 37 patents)

5. Nagaraj Govindappa (15 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…